TD Cowen Reiterates Buy Rating on Benitec BioPharma (BNTC): "strong POC to support Ph3 success" Mar 9, 2026 12:44PM
TD Cowen on Benitec BioPharma (BNTC): 'Updated Interim Ph1/2 '301 OPMD Dysphagia Data Impresses' Jan 12, 2026 09:17AM
Benitec Biopharma prices $100 million stock offering at $13.50 per share Nov 6, 2025 12:19AM
Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering Nov 6, 2025 12:19AM
Benitec Biopharma announces public stock offering Nov 5, 2025 04:43PM


Nov 5, 2025 04:43PM Benitec Biopharma Inc. Announces Proposed Public Offering
Jul 7, 2025 05:43AM TD Cowen Starts Benitec BioPharma (BNTC) at Buy
Mar 25, 2025 08:00AM Benitec Biopharma (BNTC) Prices $30M Share Offering at $13/sh
Mar 25, 2025 08:00AM Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
Feb 26, 2025 07:00AM Benitec Biopharma to Participate in Upcoming Conferences in March